Marengo Asia and Karkinos collaborate to cultivate comprehensive cancer care solutions in India

The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers

Lupin receives tentative approval from USFDA for Dolutegravir and Rilpivirine Tablets

Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of US $666 million in the US (IQVIA MAT September 2022)

1st G20 Health Working Group Meeting to commence on 18th January at Thiruvananthapuram

India's G20 Presidency will focus on three main priorities: Health Emergencies Prevention, Preparedness and Response (One Health & AMR); Access and Availability to Affordable Medical Countermeasures (Vaccines, Therapeutics, and Diagnostics); and Digital Health

USFDA inspections gather pace; Indian pharma companies equipped to handle disruptions

The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22

Vikas Lifecare’s in-house R&D Unit gets DSIR recognition

This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies

China, South Korea, and India driving innovation in medical robotics in APAC, says GlobalData

APAC to see a reduction in imported surgical robotics

LF is not a neglected disease but a priority disease for elimination: Dr. Mandaviya

Global (68M) cardiomyopathies market set to reach $9.63 bn by 2031: GlobalData

The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%

Genome sequencing solutions will help to bring precision in lung cancer therapy, says GlobalData

APAC region contributed around 50% of the in-vitro diagnostics market in 2022

Apollo Genomics Institutes launched at Apollo Hospitals Navi Mumbai

Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders